J W ten Cate

Duke University — United States

Medicine · Health Sciences

49h-index8.3kcitations247works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Venous Thromboembolism Diagnosis and Management(63), Blood Coagulation and Thrombosis Mechanisms(54), Antiplatelet Therapy and Cardiovascular Diseases(27), Immune Response and Inflammation(23), Atrial Fibrillation Management and Outcomes(19)

Publications247 total

RSV Vaccination Rates Among Eligible Patients After Abrysvo Availability: Patient Factors
American Journal of Obstetrics and Gynecology·2024Open Access
RSV Vaccination Rates Among Eligible Pregnant Patients After Abrysvo Availability: Provider Counseling and Patient Acceptance
American Journal of Obstetrics and Gynecology·2024Open Access
Morbidity in Expectant Management of Pre-viable Preterm Prelabor Rupture of Membranes
American Journal of Obstetrics and Gynecology·2024Open Access
Neonatal Survival and Morbidity Following Expectant Management of Previable Premature Rupture of Membranes at a Single Center
American Journal of Obstetrics and Gynecology·2024Open Access
Platelet Function and Arachidonic Acid Metabolism in the Myeloproliferative Syndrome: The Role of Lipoxygenase in Platelet Functioning
2019
Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression
Alimentary Pharmacology & Therapeutics·2001· 41 cited
New frontiers in deep vein thrombosis management: Introduction
Seminars in Hematology·2000
New frontiers in deep vein thrombosis management: Conclusions
Seminars in Hematology·2000
Antiplatelet Therapy and Other Interventions after Revascularisation Procedures in Patients with Peripheral Arterial Disease: a Meta-analysis
European Journal of Vascular and Endovascular Surgery·2000· 63 citedOpen Access
Evolution of therapies in deep vein thrombosis management.
PubMed·1999· 4 cited
[Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
PubMed·1999
Review: Infectious Diseases and Coagulation Disorders
The Journal of Infectious Diseases·1999· 207 citedOpen Access
[Clinical researchers and the pharmaceutical industry].
PubMed·1999
Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients
Transplantation Proceedings·1999· 4 citedOpen Access
Antikoagulatorische Therapie der venösen Thrombose
Hämostaseologie·1999
Therapie mit Antithrombinkonzentraten
Hämostaseologie·1999
Antithrombotic Drugs in the Primary Medical Management of Intermittent Claudication: A Meta-analysis
Thrombosis and Haemostasis·1999· 59 cited
Recent Advances in the Treatment of Venous Thromboembolism: Implications for the Next Century
The Journal of the Royal College of Physicians of Edinburgh·1998
Primary Venous Thromboembolism and Cancer Screening
New England Journal of Medicine·1998· 19 cited
Are Safety Committees Really Safe?
Scottish Medical Journal·1998· 2 cited
page 1 of 13Next →

Frequent Co-authors

Marcel Levi(10), Tom van der Poll(9), Hugo Ten Cate(8), S J van Deventer(8), H. R. Büller(4), H.R. Büller(3), Harry R. Büller(3), Sander J. H. van Deventer(3), Hans Pannekoek(3), C. Erik Hack(3), H R Büller(3), L. M. M. Jongbloets(3), Harriët Heijboer(3), C. S. P. Jenkins(3), Paolo Prandoni(2), Alberto Cogo(2), Dario Casara(2), A.W.A. Lensing(2), Frits J. Berends(2), C. Erik Hack(2)